COO
Price
$73.30
Change
+$0.28 (+0.38%)
Updated
Jul 3 closing price
Capitalization
19.72B
54 days until earnings call
FEMY
Price
$0.93
Change
-$0.02 (-2.11%)
Updated
Jul 3 closing price
Capitalization
33.56M
33 days until earnings call
Interact to see
Advertisement

COO vs FEMY

Header iconCOO vs FEMY Comparison
Open Charts COO vs FEMYBanner chart's image
Cooper Companies (The)
Price$73.30
Change+$0.28 (+0.38%)
Volume$1.49M
Capitalization19.72B
Femasys
Price$0.93
Change-$0.02 (-2.11%)
Volume$24.13K
Capitalization33.56M
COO vs FEMY Comparison Chart in %
Loading...
COO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FEMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COO vs. FEMY commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COO is a Buy and FEMY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (COO: $73.30 vs. FEMY: $0.93)
Brand notoriety: COO and FEMY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: COO: 57% vs. FEMY: 7%
Market capitalization -- COO: $19.72B vs. FEMY: $33.56M
COO [@Medical Specialties] is valued at $19.72B. FEMY’s [@Medical Specialties] market capitalization is $33.56M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COO’s FA Score shows that 0 FA rating(s) are green whileFEMY’s FA Score has 0 green FA rating(s).

  • COO’s FA Score: 0 green, 5 red.
  • FEMY’s FA Score: 0 green, 5 red.
According to our system of comparison, FEMY is a better buy in the long-term than COO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COO’s TA Score shows that 4 TA indicator(s) are bullish while FEMY’s TA Score has 5 bullish TA indicator(s).

  • COO’s TA Score: 4 bullish, 6 bearish.
  • FEMY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, FEMY is a better buy in the short-term than COO.

Price Growth

COO (@Medical Specialties) experienced а +5.18% price change this week, while FEMY (@Medical Specialties) price change was -5.28% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.95%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was -0.02%.

Reported Earning Dates

COO is expected to report earnings on Aug 27, 2025.

FEMY is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Medical Specialties (+1.95% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COO($19.7B) has a higher market cap than FEMY($33.6M). COO has higher P/E ratio than FEMY: COO (68.09) vs FEMY (4.17). FEMY YTD gains are higher at: -15.336 vs. COO (-20.265). COO has higher annual earnings (EBITDA): 895M vs. FEMY (-11.83M). COO has more cash in the bank: 135M vs. FEMY (8.69M). FEMY has less debt than COO: FEMY (2.86M) vs COO (2.77B). COO has higher revenues than FEMY: COO (3.67B) vs FEMY (1.09M).
COOFEMYCOO / FEMY
Capitalization19.7B33.6M58,631%
EBITDA895M-11.83M-7,564%
Gain YTD-20.265-15.336132%
P/E Ratio68.094.171,634%
Revenue3.67B1.09M335,407%
Total Cash135M8.69M1,553%
Total Debt2.77B2.86M96,822%
FUNDAMENTALS RATINGS
COO: Fundamental Ratings
COO
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
83
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
86
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COOFEMY
RSI
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
65%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 22 days ago
57%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
57%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
65%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
COO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FEMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QQQH52.750.45
+0.86%
NEOS Nasdaq-100 Hdg Eq Inc ETF
SIXP29.420.12
+0.39%
AllianzIM US Lrg Cp 6M Bfr10 Mar/Sep ETF
JIVE69.810.25
+0.37%
JPMorgan International Value ETF
NEA11.010.01
+0.09%
Nuveen AMT-Free Quality Municipal Income Fund
LDSF18.98-0.01
-0.05%
First Trust Low Dur Strat Foc ETF

COO and

Correlation & Price change

A.I.dvisor indicates that over the last year, COO has been loosely correlated with ALC. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if COO jumps, then ALC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COO
1D Price
Change %
COO100%
+0.38%
ALC - COO
51%
Loosely correlated
-1.70%
A - COO
49%
Loosely correlated
+0.60%
DHR - COO
44%
Loosely correlated
+0.35%
MTD - COO
43%
Loosely correlated
+0.28%
BIO - COO
43%
Loosely correlated
+0.36%
More

FEMY and

Correlation & Price change

A.I.dvisor tells us that FEMY and OM have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FEMY and OM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FEMY
1D Price
Change %
FEMY100%
-1.95%
OM - FEMY
31%
Poorly correlated
+1.55%
LUCD - FEMY
31%
Poorly correlated
-1.90%
BLFS - FEMY
29%
Poorly correlated
+0.40%
GH - FEMY
28%
Poorly correlated
+0.64%
COO - FEMY
28%
Poorly correlated
+0.38%
More